AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
60 Degrees Pharmaceuticals, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00NXBJGR3
0.87▼ 0.01 (-0.66%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
0.88
Day's Range
0.82 – 0.93
52-Week Range
0.34 – 8.62
Volume
13.1K
Avg Volume
163.5K
Share Statistics
Shares Outstanding
Employees
3
Exchange
XNAS
Listed
2023-07-12
Share count as of August 14, 2026

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)
What is 60 Degrees Pharmaceuticals, Inc. Common Stock's Market Cap?
60 Degrees Pharmaceuticals, Inc. Common Stock's Market Cap is $3.1M, based on as-reported figures from SEC (XBRL) filings.
What is 60 Degrees Pharmaceuticals, Inc. Common Stock's Enterprise Value?
60 Degrees Pharmaceuticals, Inc. Common Stock's Enterprise Value is $11.8M, based on as-reported figures from SEC (XBRL) filings.
What is 60 Degrees Pharmaceuticals, Inc. Common Stock's Price / Sales?
60 Degrees Pharmaceuticals, Inc. Common Stock's Price / Sales is 2.8×, based on as-reported figures from SEC (XBRL) filings.
What is 60 Degrees Pharmaceuticals, Inc. Common Stock's EV / Revenue?
60 Degrees Pharmaceuticals, Inc. Common Stock's EV / Revenue is 10.6×, based on as-reported figures from SEC (XBRL) filings.
What is 60 Degrees Pharmaceuticals, Inc. Common Stock's EV / EBITDA?
60 Degrees Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is 60 Degrees Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?
60 Degrees Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $1.1M, based on as-reported figures from SEC (XBRL) filings.
What is 60 Degrees Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?
60 Degrees Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$8.6M, based on as-reported figures from SEC (XBRL) filings.
What is 60 Degrees Pharmaceuticals, Inc. Common Stock's EBITDA?
60 Degrees Pharmaceuticals, Inc. Common Stock's EBITDA is -$8.5M, based on as-reported figures from SEC (XBRL) filings.
What is 60 Degrees Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?
60 Degrees Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -2.45, based on as-reported figures from SEC (XBRL) filings.
What is 60 Degrees Pharmaceuticals, Inc. Common Stock's EBITDA Margin?
60 Degrees Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -769.3%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SXTPAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Product Revenues – net of Discounts and Rebates
YoY growth+27.1%+25.6%+223.4%
Cost of Revenues
Gross Profit
% of revenue27.3%60.2%-22.9%
Research Revenues—
Net Revenue
Operating Expenses:
Research and Development
General and Administrative Expenses
Total Operating Expenses
% of revenue1119.7%696.5%529.3%
Loss from Operations
% of revenue-1092.4%-632.0%-531.4%
Interest Expense
Change in Fair Value of Derivative Liabilities
Other Income, net
Total Interest and Other Income (Loss), net——
Loss from Operations before Provision for Income Taxes
Provision for Income Taxes (Note 10)—
Net Loss including Noncontrolling Interest
% of revenue-1089.8%-1665.0%-529.5%
Net Loss – Noncontrolling Interest
Net Loss – attributed to 60 Degrees Pharmaceuticals, Inc.
% of revenue-1089.2%-474.2%-529.3%
Net Loss
% of revenue-1089.8%-1665.0%-529.5%
Cumulative Dividends on Series A Preferred Stock
Net Loss - attributed to common stockholders
Basic (in Dollars per share)—
Diluted (in Dollars per share)—